McDonnell Boehnen Hulbert & Berghoff LLP partners Paul Berghoff and Ann Palma
are cited in an October 31, 2016 edition of Law360.com in an article entitled, “Pfizer, Others Tell High Court PTAB Unfair To Patent Owners.” Two major drug industry groups and a range of large companies including Pfizer and Qualcomm have urged the U.S. Supreme Court to rule that the same Patent Trial and Appeal Board panel cannot both institute and decide inter partes reviews, calling the system unfair to patent owners. 3M and the other amici are represented by MBHB partners Paul Berghoff and Ann Palma. View the article
